Follow on Google News News By Tag * Dermatological Drug * Skin Diseases * Generic Drug * Dermatitis * Skin Infections * Acne * Psoriasis * More Tags... Industry News News By Location Country(s) Industry News
Follow on Google News | Brand new report "Dermatological Drugs: World Market 2011-2026" Published by Visiongain Ltd.Dermatological drugs form an important segment of the global pharma market, with sales of over $25bn in 2009. New drugs with improved safety and efficacy can gain significant market shares in the future, our study reveals.
By: Visiongain Ltd. - how you can see the future of the industry and market Would you like to know how the industry and market for dermatological drugs will develop? There will be trends to watch from 2010 onwards, with areas of high revenue growth. You can have our new report now, staying ahead, saving time and aiding your decisions. There, you will see where the greatest opportunities in treating skin disorders will occur. In particular, our new study examines drug markets for treating: • Dermatitis • Skin infections • Acne • Psoriasis. There are high revenues to be made in this sector from 2010 to 2026. We show how you can benefit from the sector's developments and potential. Dermatological drugs form an important segment of the global pharma market, with sales of over $25bn in 2009. New drugs with improved safety and efficacy can gain significant market shares in the future, our study reveals. Novel and generic drug producers can benefit from that sector this decade, our analyses show and explain. There are opportunities for small-molecule and biologic drugs. We cover the world market, its main segments and revenues in leading regions. The introduction and commercial success of biologics led to an expansion of the skin treatments market and highlighted the commercial rewards on offer in this sector. What new types of agent will enter the market, and can those drugs dominate? Where can you find the best commercial opportunities from 2010 onwards? What are the key drivers and restraints in the sector? We show how you can benefit there, letting you assess dermatological market potential now. Analysis and expert views to aid your work - so you won't be left behind Our new report provides you with revenue forecasts, market share analyses, R&D pipeline developments and expert opinion. That way, you can assess prospects, opportunities and threats in the sector. It is that combination of data that sets us apart. We include 99 tables and figures and two expert interviews (shown in the accompanying lists). You can stay ahead by ordering our report today, benefiting your analyses and commercial ideas. Dermatological Drugs: World Market 2011-2026 shows you revenue trends, opportunities and challenges Our report gives you the following advantages: • You will receive hard data for the dermatological treatments sector - especially our revenue forecasts - helping you to stay ahead • You will discover revenue trends for the overall market and its main components from 2009 to 2026 - showing you where commercial potential will occur • You will see the revenue prospects for leading products from 2009 to 2026, with discussions of market potential and competition • You will find revenue predictions for leading national markets from 2009 to 2026 (US, Japan, UK, Germany, France, Spain, Italy, China and India) • You will assess leading organisations in skin disorder treatments, discovering their activities and prospects • You will investigate the drivers, restraints, competition and opportunities influencing the skin disorders market from 2010 onwards • You will review the R&D pipeline, assessing the potential of developments • You will investigate unmet and under-met needs in that sector, with therapeutic requirements and commercial opportunities discussed • You will view expert opinion from our survey, including interview transcripts • You will find out where the sector is heading - technology, competition, revenues and other aspects of the industry and market. You can have our report today Our new study can benefit everybody interested in the development and sale of treatments for skin disorders. You can see where the industry and market are heading, assessing the opportunities, requirements and challenges there. You can find answers and trends - we aim to save you time and aid your decisions. Order our report now, making sure you don't miss out. Please let us help today. Visiongain is a trading partner with the US Federal Government CCR Ref number: KD4R6 Contact Person: Bijal Patel bijal.patel@ 0044(0)20 7549 9946 # # # Visiongain is an independent business information provider for the Telecoms, Pharmaceutical and Defence industries. We organise conferences, publish reports and newsletters, and provide consultancy services. End
Account Email Address Disclaimer Report Abuse
|
|